Fatigue in patients undergoing radiation therapy: an observational study

Area of Science:

• Oncology
• Nutrition Science
• Quality of Life Research

Background:

• Fatigue affects approximately 80% of patients undergoing radiation therapy, significantly diminishing their quality of life.
• Cancer-related fatigue is a prevalent and debilitating symptom impacting treatment adherence and overall well-being.

Purpose of the Study:

• To evaluate the efficacy of a specific nutraceutical (Prother) in managing fatigue.
• To assess changes in fatigue severity before, during, and after nutraceutical administration in breast and prostate cancer patients undergoing radiation therapy.

Main Methods:

• A study involving 30 cancer patients (20 breast, 10 prostate) who received a nutraceutical (Prother).
• Patients with moderate-to-mild fatigue (score 4-6 on MD Anderson Fatigue Scale) were given Prother (20g/day for 10 days, then 10g/day for 20 days).
• Fatigue levels were reassessed using the same scale after 10 and 30 days of nutraceutical administration; a control group of 30 patients did not receive Prother.

Main Results:

• The nutraceutical Prother demonstrated effectiveness in mitigating fatigue among all patients experiencing moderate-to-mild symptoms.
• Significant improvements in fatigue levels were observed in the group receiving the nutraceutical compared to the control group.

Conclusions:

• Administration of Prother was effective in improving the quality of life for cancer patients undergoing radiation therapy.
• Prother supplementation enhanced patient compliance with radiation treatment regimens.